BW710
BW710 is an orally active fibroblast growth factor receptor 2 (FGFR2) inhibitor. BW710 inhibits the proliferation of BaF3-FGFR2 cells with an IC50 of 2.8 nM. BW710 abolishes FGFR2 enzymatic activity and is selective against other 75 tyrosine kinases including FGFR1, FGFR3, and FGFR4 at 1 μM. BW710 suppresses the FGFR2 signaling and selectively inhibits FGFR2-driven cancer cell proliferation. BW710 displays reasonable pharmacokinetic properties with an oral bioavailability of 29 % in mice[1].
Product Specifications
UNSPSC
12352005
Target
FGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
NC(N=CN=C12)=C2C(C3=CC=C(S4(CCCCCN=4)=O)C=C3)=C(N1C)C(C=C5)=C(F)C=C5NC(C(C)=C)=O
Molecular Formula
C28H29FN6O2S
Molecular Weight
532.63
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ERHP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Recombinant Human Testis-expressed sequence 12 protein(TEX12)